About
Adam Blum returns to talk about what sits underneath his clinical-trial matcher: PRomop, an open-source patient record built on OMOP. Now CTO of HealthKey.ai, which acquired CancerBot this year, Adam argues that organizations can replace their transactional, analytics, and decision-ready stores with one, and that a single flat record per disease is enough. Leon Rozenblit pushes back on whether one record can serve many questions, and Steve Labkoff presses on staleness and where the AI actually lives. Steve advises HealthKey and co-authored the PRomop paper with Adam.